Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Eren D. Yeh"'
Autor:
Catherine S. Giess, Andro L. Licaros, Dylan C. Kwait, Eren D. Yeh, Ronilda Lacson, Ramin Khorasani, Sona A. Chikarmane
Publikováno v:
Journal of the American College of Radiology. 20:207-214
The aim of this study was to compare screening mammography performance metrics for immediate (live) interpretation versus offline interpretation at a cancer center.An institutional review board-approved, retrospective comparison of screening mammogra
Autor:
Eren D. Yeh, Leah H. Portnow
Publikováno v:
Seminars in Ultrasound, CT and MRI. 44:8-11
Autor:
Filipa Lynce, Eren D. Yeh, Meredith M. Regan, Lei Qin, Camden P. Bay, Ian Krop, Beth T Harrison, Faina Nakhlis, Jennifer Bellon, Beth Overmoyer
Publikováno v:
Cancer Research. 82:P2-12
Background: Inflammatory breast cancer (IBC) is unresectable at presentation, thus neoadjuvant systemic therapy (NAS) is the primary treatment for this aggressive disease. Eribulin (E) (Eisai Co., Ltd) is a synthetic analog of Halichondroin B that su
Autor:
Sona A. Chikarmane, Christine M. Denison, Sughra Raza, Eva C. Gombos, Elisabeth P. Frost, Catherine S. Giess, Eren D. Yeh, Camden P. Bay
Publikováno v:
Clinical Imaging. 75:90-96
Objective To compare lesion conspicuity on synthetic screening mammography (SM) plus digital breast tomosynthesis (DBT) versus full field digital mammography (FFDM) plus DBT. Materials and methods Seven breast imagers each prospectively evaluated 107
Abstract PS14-21: Refining loco-regional therapy for inflammatory breast cancer protocol in progress
Autor:
Tari A. King, Jean Landry, Heather A. Jacene, Faina Nakhlis, Eren D. Yeh, Jennifer R. Bellon, Beth Overmoyer, Meredith M. Regan, Beth T. Harrison, Elizabeth A. Mittendorf
Publikováno v:
Cancer Research. 81:PS14-21
Background: Inflammatory breast cancer (IBC) is the most aggressive locally advanced breast cancer subtype. It is associated with loco-regional recurrence rates of 12-25%, and neoadjuvant chemotherapy (NAC) followed by modified radical mastectomy and
Publikováno v:
Academic Radiology. 27:757-763
To evaluate conspicuity of screen-detected cancers on two-dimensional synthetic mammography (SM) reconstructed from digital breast tomosynthesis (DBT) compared to two-dimensional full field digital mammography (FFDM).IRB-approved retrospective review
Autor:
Heather A. Jacene, Meredith M. Regan, Yoon S. Chun, Jennifer R. Bellon, Tari A. King, Eren D. Yeh, Laura E.G. Warren, Stephanie A. Caterson, Faina Nakhlis, Laura S. Dominici, Beth Overmoyer
Publikováno v:
The Breast Journal. 26:384-390
Inflammatory breast cancer (IBC) exhibits dermal lymphatic involvement at presentation, and thus, the standard surgical approach is a nonskin-sparing modified radical mastectomy (MRM) without breast reconstruction (BR). In this study, we evaluated im
Autor:
Eren D. Yeh, Marie Claire Remolano, Beth Overmoyer, Heather A. Jacene, Meredith M. Regan, Julia Schlossman, Beth T. Harrison, Kelly A. Hirko, Jennifer M. Rosenbluth, Caroline Block, Ana C. Garrido-Castro, Faina Nakhlis
Publikováno v:
American journal of clinical oncology. 44(9)
OBJECTIVES Dermal lymphatic invasion (DLI) with tumor emboli is a common pathologic characteristic of inflammatory breast cancer (IBC), although its presence is not required for diagnosis. We examined whether documented DLI on skin biopsy was associa
Autor:
J Schlossman, Eren D. Yeh, Emily Schlosnagle, Beth Overmoyer, Kelly A. Hirko, Faina Nakhlis, Heather A. Jacene, Beth T. Harrison
Publikováno v:
Cancer Research. 79:P6-09
Purpose: The pathologic hallmark of inflammatory breast cancer (IBC) is the presence of tumor emboli within the papillary and reticular dermis of the skin, termed dermal lymphatic invasion (DLI). DLI can be confirmed with a skin-punch biopsy in appro
Autor:
Meghan E. Meyer, Tal Sella, Eren D. Yeh, Ann H. Partridge, Kathryn J. Ruddy, William T. Barry, Anne A. Dowton
Publikováno v:
The breast journalREFERENCES. 26(9)
The role of breast magnetic resonance imaging (MRI) in the screening of breast cancer survivors with remaining breast tissue is not well studied. We sought to evaluate the outcomes of screening breast MRI in a cohort of breast cancer survivors. A pop